Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis

Journal of Neuroscience

Volumn 22, Issue 20, 2002, Pages 8951-8960

  Larsen, Kristin E ^a   Fon, Edward A ^b   Hastings, Teresa G ^c   Edwards, Robert H ^d   Sulzer, David ^a,e  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Black Building ^*  (United States)

Author keywords

Autophagy; Dopamine; Methamphetamine; Neurodegeneration; Oxidative stress; Ventral midbrain; VMAT2

Indexed keywords

BRAIN MONOAMINE; CARRIER PROTEIN; DOPAMINE; METHAMPHETAMINE; OXYGEN RADICAL; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; AUTOPHAGY; CELL DEATH; CELL GRANULE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; ELECTRON MICROSCOPY; ENZYME ACTIVITY; FLUORESCENCE ANALYSIS; KNOCKOUT MOUSE; MESENCEPHALON; MOUSE; NERVE CELL DEGENERATION; NEUROTOXICITY; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNAPSE VESICLE;

EID: 0037109770     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-20-08951.2002     Document Type: Article

References (60)

1. Acikgoz O, Gonenc S, Kayatekin BM, Uysal N, Pekcetin C, Semin I, Gure A (1998) Methamphetamine causes lipid peroxidation and an increase in superoxide dismutase activity in the rat striatum. Brain Res 813:200-202.
2. Axt KJ, Commins DL, Vosmer G, Seiden LS (1990) α-Methyl-p-tyrosine pretreatment partially prevents methamphetamine-induced endogenous neurotoxin formation. Brain Res 515:269-276.
3. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
4. Cadet JL, Sheng P, Ali S, Rothman R, Carlson E, Epstein C (1994) Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J Neurochem 62:380-383.
5. Clausing P, Gough B, Holson RR, Slikker W, Bowyer JF (1995) Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra, and plasma after dosage that produces either behavioral or neurotoxic effects. J Pharmacol Exp Ther 274:614-621.
6. Cubells J, Rayport S, Rajendran G, Sulzer D (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J Neurosci 14:2260-2271.
7. De Vito MJ, Wagner GC (1989) Methamphetamine-induced neuronal damage: A possible role for free radicals. Neuropharmacology 28:1145-1150.
8. Di Monte DA, Royland JE, Jakowec MW, Langston JW (1996) Role of nitric oxide in methamphetamine neurotoxicity: Protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase. J Neurochem 67:2443-2450.
9. 3H-a-methyl-m-tyramine from rat striatum in vitro. Eur J Pharmacol 35:225-228.
10. Dougan D, Duffield A, Duffield P, Wade D (1983) The effects of(+)-amphetamine, α-methyltyrosine, and α-methylphenylalanine on the concentrations of m-tyramine in rat striatum. Br J Pharmacol 80:309-314.
11. Duffield P, Dougan D, Wade D, Duffield A (1982) Absence of α-methyldopamine in rat striatum after chronic administration of d-amphetamine. Life Sci 30:1701-1705.
12. Edwards RH (1993) Neuronal degeneration and the transport of neurotransmitters. Annu Neurol 34:638-645.
13. Fischer JF, Cho AK (1979) Chemical release of dopamine from striatal homogenates: Evidence for an exchange diffusion model. J Pharmacol Exp Ther 208:203-209.
14. Fleckenstein AE, Gibb JW, Hanson GR (2000) Differential effects of stimulants on monoaminergic transporters: Pharmacological consequences and implications for neurotoxicity. Eur J Pharmacol 406:1-13.
15. Fon EA, Pothos EN, Sun B-C, Killeen N, Sulzer D, Edwards RH (1997) Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron 19:1271-1283.
16. Fornstedt B, Carlsson A (1989) A marked rise in 5-S-cysteinyl-dopamine levels in guinea pig striatum following reserpine treatment. J Neural Transm 76:155-161.
17. Fumagalli F, Gainetdinov RR, Valenzano KJ, Caron MG (1998) Role of dopamine transporter in methamphetamine-induced neurotoxicity: Evidence from mice lacking the transporter. J Neurosci 18:4861-4869.
18. Fumagalli F, Gainetdinov RR, Wang YM, Valenzano KJ, Miller GW, Caron MG (1999) Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. J Neurosci 19:2424-2431.
19. Hastings TG, Berman SB (1999) Dopamine-induced toxicity and quinone modification of proteins: Implication for Parkinson's disease. In: Role of Catechol Quinone Species in Cellular Toxicity (Creveling CR, ed), pp 69-89. Johnson City, TN: F. P. Graham Publishing.
20. Hastings TG, Lewis DA, Zigmond MJ (1996) Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci USA 93:1956-1961.
21. Itzhak Y, Gandia C, Huang PL, Ali SF (1998) Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopamine neurotoxicity. J Pharmacol Exp Ther 284:1040-1047.
22. Jones SR, Gainetdinov RR, Wightman RM, Caron MG (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18:1979-1986.
23. Jones SR, Joseph JD, Barak LS, Caron MG, Wightman RM (1999) Dopamine neuronal transport kinetics and effects of amphetamine. J Neurochem 73:2406-2414.
24. Kita T, Takahashi M, Kubo K, Wagner GC, Nakashima T (1999) Hydroxyl radical formation following methamphetamine administration to rats. Pharmacol Toxicol 85:133-137.
25. Kooy NW, Royall J, Ischiropoulos H (1997) Oxidation of 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 5:227-231.
26. Larsen K, Sulzer D (2002) Autophagy in neurons: A review. Histol Histopathol 17:897-908.
27. LaVoie MJ, Hastings TG (1999) Dopamine quinone formation and protein modification associated with striatal neurotoxicity of methamphetamine: Evidence against a role for extracellular dopamine. J Neurosci 19:1484-1491.
28. Liu Y, Peter D, Roghani A, Schuldiner S, Prive GG, Eisenbergy D, Brecha N, Edwards RH (1992) A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell 70:539-551.
29. Lotharius J, O'Malley KL (2000) The parkinsonism-inducing drug L-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J Biol Chem 275:38581-38588.
30. Lotharius J, O'Malley KL (2001) Role of mitochondrial dysfunction and dopamine-dependent oxidative stress in amphetamine-induced toxicity. Ann Neurol 49:79-89.
31. Maron RY, Stern BI, Kanner BI, Schuldiner S (1983) Functional asymmetry of the amine transporter from chromaffin granules. J Biol Chem 258:11476-11481.
32. Mena MA, Davila V, Sulzer D (1997) Neurotrophic effects of L-DOPA in postnatal midbrain dopamine neuron/cortical astrocyte cocultures. J Neurochem 69:1398-1408.
33. Mundorf ML, Hochstetler SE, Wightman RM (1999) Amine weak bases disrupt vesicular storage and promote exocytosis in chromaffin cells. J Neurochem 73:2397-2405.
34. Petersén Å, Larsen KE, Behr GG, Romero N, Przedborski S, Brundin P, Sulzer D (2001) Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. Hum Mol Genet 10:1243-1254.
35. Philipp E (1987) Assay for tyrosine hydroxylase in hypothalamic homogenates using high-performance liquid chromatography with electrochemical detection. J Chromatogr 419:27-36.
36. Pifl C, Drobny H, Reither H, Hornykiewicz O, Singer EA (1995) Mechanism of the dopamine-releasing actions of amphetamine and cocaine: Plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol Pharmacol 47:368-373.
37. Possel H, Noack H, Augustin W, Keilhoff G, Wolf G (1997) 2,7-dihydrochlorofluorescein diacetate as a fluorescent marker for peroxynitrate formation. FEBS Lett 416:175-178.
38. Pothos E, Davila V, Sulzer D (1998) Presynaptic recording of quanta from midbrain dopamine neurons and modulation of the quantal size. J Neurosci 18:4106-4118.
39. Pothos E, Larsen K, Krantz D, Liu Y-J, Edwards R, Sulzer D (2000) Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size. J Neurosci 20:7297-7306.
40. Ricaurte GA, Guillery RW, Seiden LS, Schuster CR, Moore RY (1982) Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res 235:93-103.
41. Ricaurte GA, Seiden LS, Schuster CR (1983) Increased dopamine metabolism in the rat neostriatum after toxic doses of d-methylamphetamine. Neuropharmacology 22:1383-1388.
42. Rota C, Chignell CF, Mason RP (1999) Evidence for free radical formation during the oxidation of 2′7′-dichlorofluorescin to the fluorescent dye 2′,7′-dichlorofluorescein by horseradish peroxidase: Possible implications for oxidative stress measurements. Free Radic Biol Med 27:873-881.
43. Schmitz Y, Lee CJ, Schmauss C, Gonon F, Sulzer D (2001) Amphetamine distorts stimulation-dependent dopamine overflow: Effects on D2 autoreceptors, transporters, and synaptic vesicle stores. J Neurosci 21:5916-5924.
44. Seiden L, Ricaurte G (1987) Neurotoxicity of methamphetamine and related drugs. In: Pyschopharmacology: The Third Generation of Progress (Meltzer H, ed), pp 359-366. New York: Raven.
45. Seiden LS, Vosmer G (1984) Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine. Pharmacol Biochem Behav 21:29-31.
46. Sidell K, Olson S, Ou J, Zhang Y, Amarnath V, Montine T (2001) Cysteine and mercapturate conjugates of oxidized dopamine are in human striatum but only the cysteine conjugate impedes dopamine trafficking in vitro and in vivo. J Neurochem 79:510-521.
47. Sonders MS, Zhu SJ, Zahniser NR, Kavanaugh MP, Amara SG (1997) Multiple ionic conductances of the human dopamine transporter: The actions of dopamine and psychostimulants. J Neurosci 17:960-974.
48. Srinivasan A, Roth K, Sayers R, Schindler K, Wong A, Fritz L, Tomaselli K (1998) In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system. Cell Death Differ 5:1004-1016.
49. Stephans SE, Yamamoto BK (1994) Methamphetamine-induced neurotoxicity: Roles for glutamate and dopamine efflux. Synapse 17:203-209.
50. Sulzer D, Zecca L (2000) Intraneuronal dopamine-quinone synthesis: A review. Neurotoxicity Res 1:181-195.
51. Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15:4102-4108.
52. Sulzer D, St. Remy C, Rayport S (1996) Reserpine inhibits amphetamine action in ventral midbrain culture. Mol Pharmacol 49:338-342.
53. Sulzer D, Bogulavsky J, Larsen K, Karatekin E, Kleinman M, Turro N, Krantz D, Edwards R, Greene L, Zecca L (2000) Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc Natl Acad Sci USA 97:11869-11874.
54. Uhl GR (1998) Hypothesis: The role of dopaminergic transporters in selective vulnerability of cells in Parkinson's disease. Ann Neurol 43:555-560.
55. Wagner GC, Carelli RM, Jarvis MF (1985a) Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats. Res Commun Chem Pathol Pharmacol 47:221-228.
56. Wagner GC, Lucot JB, Schuster CR, Seiden LS (1985b) α-Methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes. Brain Res 270:285-288.
57. Wan FJ, Shiah IS, Lin HC, Huang SY, Tung CS (2000) Nomifensine attenuates d-amphetamine-induced dopamine terminal neurotoxicity in the striatum of rats. Chin J Physiol 43:69-74.
58. Whitehead R, Ferrer J, Javitch J, Justice J (2001) Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter. J Neurochem 76:1242-1251.
59. Yuan J, Callahan BT, McCann UD, Ricaurte GA (2001) Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity. J Neurochem 77:1338-1347.
60. Zhang F, Dryhurst G (1994) Effects of L-cysteine on the oxidation chemistry of dopamine: New reaction pathways of potential relevance to idiopathic Parkinson's disease. J Med Chem 37:1084-1098.